Kim Kyung-su and LMK Investment Association No.1 Acquire 7.01% Stake in InnoTherapy

InnoTherapy announced on the 16th that Kim Kyung-soo and LMK Investment Association No.1 purchased 447,820 shares (7.01%) on the market. According to the electronic disclosure system, Kim Kyung-soo's purpose of holding is "influence on management rights."

He stated, "With patience and trust, I will observe the current management's performance and work towards the healthy long-term growth of InnoTherapy and the protection of minority shareholders' rights." He added, "Within the scope and methods permitted by relevant laws, such as amendments to the articles of incorporation, appointment of outside directors or auditors, I plan to decide on related actions including shareholder proposals, convening general meetings, and recommending proxy voting."

Kim Kyung-soo, a former fund manager at Hana Securities, was appointed vice president of Topco in 2021. He then led Topco Media to a turnaround into profitability and resigned in July last year. He currently serves as CEO of LMK Insight and as the representative partner of LMK Investment Association No.1. Another representative partner, Kim Dae-hwan, is currently serving as executive director at Compa Ventures.